Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati
In some Pacific Island countries, such as Solomon Islands and Fiji, active trachoma is common, but ocular Chlamydia trachomatis (Ct) infection and trachomatous trichiasis (TT) are rare. On Tarawa, the most populous Kiribati island, both the active trachoma sign "trachomatous inflammation-follic...
Saved in:
Published in | PLoS neglected tropical diseases Vol. 11; no. 9; p. e0005863 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
12.09.2017
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | In some Pacific Island countries, such as Solomon Islands and Fiji, active trachoma is common, but ocular Chlamydia trachomatis (Ct) infection and trachomatous trichiasis (TT) are rare. On Tarawa, the most populous Kiribati island, both the active trachoma sign "trachomatous inflammation-follicular" (TF) and TT are present at prevalences warranting intervention. We sought to estimate prevalences of TF, TT, ocular Ct infection, and anti-Ct antibodies on Kiritimati Island, Kiribati, to assess local relationships between these parameters, and to help determine the need for interventions against trachoma on Kiribati islands other than Tarawa.
As part of the Global Trachoma Mapping Project (GTMP), on Kiritimati, we examined 406 children aged 1-9 years for active trachoma. We collected conjunctival swabs (for droplet digital PCR against Ct plasmid targets) from 1-9-year-olds with active trachoma, and a systematic selection of 1-9-year-olds without active trachoma. We collected dried blood spots (for anti-Pgp3 ELISA) from all 1-9-year-old children. We also examined 416 adults aged ≥15 years for TT. Prevalence of TF and TT was adjusted for age (TF) or age and gender (TT) in five-year age bands.
The age-adjusted prevalence of TF in 1-9-year-olds was 28% (95% confidence interval [CI]: 24-35). The age- and gender-adjusted prevalence of TT in those aged ≥15 years was 0.2% (95% CI: 0.1-0.3%). Twenty-six (13.5%) of 193 swabs from children without active trachoma, and 58 (49.2%) of 118 swabs from children with active trachoma were positive for Ct DNA. Two hundred and ten (53%) of 397 children had anti-Pgp3 antibodies. Both infection (p<0.0001) and seropositivity (p<0.0001) were strongly associated with active trachoma. In 1-9-year-olds, the prevalence of anti-Pgp3 antibodies rose steeply with age.
Trachoma presents a public health problem on Kiritimati, where the high prevalence of ocular Ct infection and rapid increase in seropositivity with age suggest intense Ct transmission amongst young children. Interventions are required here to prevent future blindness. |
---|---|
AbstractList | Objective In some Pacific Island countries, such as Solomon Islands and Fiji, active trachoma is common, but ocular Chlamydia trachomatis (Ct) infection and trachomatous trichiasis (TT) are rare. On Tarawa, the most populous Kiribati island, both the active trachoma sign “trachomatous inflammation-follicular” (TF) and TT are present at prevalences warranting intervention. We sought to estimate prevalences of TF, TT, ocular Ct infection, and anti-Ct antibodies on Kiritimati Island, Kiribati, to assess local relationships between these parameters, and to help determine the need for interventions against trachoma on Kiribati islands other than Tarawa. Methods As part of the Global Trachoma Mapping Project (GTMP), on Kiritimati, we examined 406 children aged 1-9 years for active trachoma. We collected conjunctival swabs (for droplet digital PCR against Ct plasmid targets) from 1-9-year-olds with active trachoma, and a systematic selection of 1-9-year-olds without active trachoma. We collected dried blood spots (for anti-Pgp3 ELISA) from all 1-9-year-old children. We also examined 416 adults aged ≥15 years for TT. Prevalence of TF and TT was adjusted for age (TF) or age and gender (TT) in five-year age bands. Results The age-adjusted prevalence of TF in 1-9-year-olds was 28% (95% confidence interval [CI]: 24-35). The age- and gender-adjusted prevalence of TT in those aged ≥15 years was 0.2% (95% CI: 0.1-0.3%). Twenty-six (13.5%) of 193 swabs from children without active trachoma, and 58 (49.2%) of 118 swabs from children with active trachoma were positive for Ct DNA. Two hundred and ten (53%) of 397 children had anti-Pgp3 antibodies. Both infection (p<0.0001) and seropositivity (p<0.0001) were strongly associated with active trachoma. In 1-9-year-olds, the prevalence of anti-Pgp3 antibodies rose steeply with age. Conclusion Trachoma presents a public health problem on Kiritimati, where the high prevalence of ocular Ct infection and rapid increase in seropositivity with age suggest intense Ct transmission amongst young children. Interventions are required here to prevent future blindness. OBJECTIVEIn some Pacific Island countries, such as Solomon Islands and Fiji, active trachoma is common, but ocular Chlamydia trachomatis (Ct) infection and trachomatous trichiasis (TT) are rare. On Tarawa, the most populous Kiribati island, both the active trachoma sign "trachomatous inflammation-follicular" (TF) and TT are present at prevalences warranting intervention. We sought to estimate prevalences of TF, TT, ocular Ct infection, and anti-Ct antibodies on Kiritimati Island, Kiribati, to assess local relationships between these parameters, and to help determine the need for interventions against trachoma on Kiribati islands other than Tarawa. METHODSAs part of the Global Trachoma Mapping Project (GTMP), on Kiritimati, we examined 406 children aged 1-9 years for active trachoma. We collected conjunctival swabs (for droplet digital PCR against Ct plasmid targets) from 1-9-year-olds with active trachoma, and a systematic selection of 1-9-year-olds without active trachoma. We collected dried blood spots (for anti-Pgp3 ELISA) from all 1-9-year-old children. We also examined 416 adults aged ≥15 years for TT. Prevalence of TF and TT was adjusted for age (TF) or age and gender (TT) in five-year age bands. RESULTSThe age-adjusted prevalence of TF in 1-9-year-olds was 28% (95% confidence interval [CI]: 24-35). The age- and gender-adjusted prevalence of TT in those aged ≥15 years was 0.2% (95% CI: 0.1-0.3%). Twenty-six (13.5%) of 193 swabs from children without active trachoma, and 58 (49.2%) of 118 swabs from children with active trachoma were positive for Ct DNA. Two hundred and ten (53%) of 397 children had anti-Pgp3 antibodies. Both infection (p<0.0001) and seropositivity (p<0.0001) were strongly associated with active trachoma. In 1-9-year-olds, the prevalence of anti-Pgp3 antibodies rose steeply with age. CONCLUSIONTrachoma presents a public health problem on Kiritimati, where the high prevalence of ocular Ct infection and rapid increase in seropositivity with age suggest intense Ct transmission amongst young children. Interventions are required here to prevent future blindness. Ocular infection with Chlamydia trachomatis causes trachoma. It is the leading infectious cause of blindness, and the target of an international campaign for elimination as a public health problem. Trachoma is endemic to Tarawa, the most populated island of Kiribati, housing approximately half the national population. However, the country has 20 inhabited islands and there were no previous trachoma prevalence data from Kiribati outside Tarawa. We set out to determine the prevalence of trachoma in the second most populated island, Kiritimati, located over 3000 km from Tarawa. In some other Pacific Island countries, ocular C . trachomatis infection is much less prevalent than the clinical signs that are used to guide interventions; we therefore looked for PCR-based evidence of current infection and antibodies to chlamydial proteins, in addition to recording clinical signs of trachoma. Our results indicate that trachoma and ocular C . trachomatis infection are prevalent on Kiritimati, and suggest that interventions are required here. The combined application of antibody, nucleic acid and clinical tools in an intervention-naïve population provides insight into their inter-relationships and the data are, therefore, of considerable interest to elimination programmes within and beyond the Pacific. Objective In some Pacific Island countries, such as Solomon Islands and Fiji, active trachoma is common, but ocular Chlamydia trachomatis (Ct) infection and trachomatous trichiasis (TT) are rare. On Tarawa, the most populous Kiribati island, both the active trachoma sign “trachomatous inflammation-follicular” (TF) and TT are present at prevalences warranting intervention. We sought to estimate prevalences of TF, TT, ocular Ct infection, and anti-Ct antibodies on Kiritimati Island, Kiribati, to assess local relationships between these parameters, and to help determine the need for interventions against trachoma on Kiribati islands other than Tarawa. Methods As part of the Global Trachoma Mapping Project (GTMP), on Kiritimati, we examined 406 children aged 1-9 years for active trachoma. We collected conjunctival swabs (for droplet digital PCR against Ct plasmid targets) from 1-9-year-olds with active trachoma, and a systematic selection of 1-9-year-olds without active trachoma. We collected dried blood spots (for anti-Pgp3 ELISA) from all 1-9-year-old children. We also examined 416 adults aged ≥15 years for TT. Prevalence of TF and TT was adjusted for age (TF) or age and gender (TT) in five-year age bands. Results The age-adjusted prevalence of TF in 1-9-year-olds was 28% (95% confidence interval [CI]: 24-35). The age- and gender-adjusted prevalence of TT in those aged ≥15 years was 0.2% (95% CI: 0.1-0.3%). Twenty-six (13.5%) of 193 swabs from children without active trachoma, and 58 (49.2%) of 118 swabs from children with active trachoma were positive for Ct DNA. Two hundred and ten (53%) of 397 children had anti-Pgp3 antibodies. Both infection (p<0.0001) and seropositivity (p<0.0001) were strongly associated with active trachoma. In 1-9-year-olds, the prevalence of anti-Pgp3 antibodies rose steeply with age. Conclusion Trachoma presents a public health problem on Kiritimati, where the high prevalence of ocular Ct infection and rapid increase in seropositivity with age suggest intense Ct transmission amongst young children. Interventions are required here to prevent future blindness. Objective In some Pacific Island countries, such as Solomon Islands and Fiji, active trachoma is common, but ocular Chlamydia trachomatis (Ct) infection and trachomatous trichiasis (TT) are rare. On Tarawa, the most populous Kiribati island, both the active trachoma sign "trachomatous inflammation-follicular" (TF) and TT are present at prevalences warranting intervention. We sought to estimate prevalences of TF, TT, ocular Ct infection, and anti-Ct antibodies on Kiritimati Island, Kiribati, to assess local relationships between these parameters, and to help determine the need for interventions against trachoma on Kiribati islands other than Tarawa. Methods As part of the Global Trachoma Mapping Project (GTMP), on Kiritimati, we examined 406 children aged 1-9 years for active trachoma. We collected conjunctival swabs (for droplet digital PCR against Ct plasmid targets) from 1-9-year-olds with active trachoma, and a systematic selection of 1-9-year-olds without active trachoma. We collected dried blood spots (for anti-Pgp3 ELISA) from all 1-9-year-old children. We also examined 416 adults aged [greater than or equal to]15 years for TT. Prevalence of TF and TT was adjusted for age (TF) or age and gender (TT) in five-year age bands. Results The age-adjusted prevalence of TF in 1-9-year-olds was 28% (95% confidence interval [CI]: 24-35). The age- and gender-adjusted prevalence of TT in those aged [greater than or equal to]15 years was 0.2% (95% CI: 0.1-0.3%). Twenty-six (13.5%) of 193 swabs from children without active trachoma, and 58 (49.2%) of 118 swabs from children with active trachoma were positive for Ct DNA. Two hundred and ten (53%) of 397 children had anti-Pgp3 antibodies. Both infection (p<0.0001) and seropositivity (p<0.0001) were strongly associated with active trachoma. In 1-9-year-olds, the prevalence of anti-Pgp3 antibodies rose steeply with age. Conclusion Trachoma presents a public health problem on Kiritimati, where the high prevalence of ocular Ct infection and rapid increase in seropositivity with age suggest intense Ct transmission amongst young children. Interventions are required here to prevent future blindness. In some Pacific Island countries, such as Solomon Islands and Fiji, active trachoma is common, but ocular Chlamydia trachomatis (Ct) infection and trachomatous trichiasis (TT) are rare. On Tarawa, the most populous Kiribati island, both the active trachoma sign "trachomatous inflammation-follicular" (TF) and TT are present at prevalences warranting intervention. We sought to estimate prevalences of TF, TT, ocular Ct infection, and anti-Ct antibodies on Kiritimati Island, Kiribati, to assess local relationships between these parameters, and to help determine the need for interventions against trachoma on Kiribati islands other than Tarawa. As part of the Global Trachoma Mapping Project (GTMP), on Kiritimati, we examined 406 children aged 1-9 years for active trachoma. We collected conjunctival swabs (for droplet digital PCR against Ct plasmid targets) from 1-9-year-olds with active trachoma, and a systematic selection of 1-9-year-olds without active trachoma. We collected dried blood spots (for anti-Pgp3 ELISA) from all 1-9-year-old children. We also examined 416 adults aged [greater than or equal to]15 years for TT. Prevalence of TF and TT was adjusted for age (TF) or age and gender (TT) in five-year age bands. The age-adjusted prevalence of TF in 1-9-year-olds was 28% (95% confidence interval [CI]: 24-35). The age- and gender-adjusted prevalence of TT in those aged [greater than or equal to]15 years was 0.2% (95% CI: 0.1-0.3%). Twenty-six (13.5%) of 193 swabs from children without active trachoma, and 58 (49.2%) of 118 swabs from children with active trachoma were positive for Ct DNA. Two hundred and ten (53%) of 397 children had anti-Pgp3 antibodies. Both infection (p<0.0001) and seropositivity (p<0.0001) were strongly associated with active trachoma. In 1-9-year-olds, the prevalence of anti-Pgp3 antibodies rose steeply with age. Trachoma presents a public health problem on Kiritimati, where the high prevalence of ocular Ct infection and rapid increase in seropositivity with age suggest intense Ct transmission amongst young children. Interventions are required here to prevent future blindness. In some Pacific Island countries, such as Solomon Islands and Fiji, active trachoma is common, but ocular Chlamydia trachomatis (Ct) infection and trachomatous trichiasis (TT) are rare. On Tarawa, the most populous Kiribati island, both the active trachoma sign "trachomatous inflammation-follicular" (TF) and TT are present at prevalences warranting intervention. We sought to estimate prevalences of TF, TT, ocular Ct infection, and anti-Ct antibodies on Kiritimati Island, Kiribati, to assess local relationships between these parameters, and to help determine the need for interventions against trachoma on Kiribati islands other than Tarawa.As part of the Global Trachoma Mapping Project (GTMP), on Kiritimati, we examined 406 children aged 1-9 years for active trachoma. We collected conjunctival swabs (for droplet digital PCR against Ct plasmid targets) from 1-9-year-olds with active trachoma, and a systematic selection of 1-9-year-olds without active trachoma. We collected dried blood spots (for anti-Pgp3 ELISA) from all 1-9-year-old children. We also examined 416 adults aged ≥15 years for TT. Prevalence of TF and TT was adjusted for age (TF) or age and gender (TT) in five-year age bands.The age-adjusted prevalence of TF in 1-9-year-olds was 28% (95% confidence interval [CI]: 24-35). The age- and gender-adjusted prevalence of TT in those aged ≥15 years was 0.2% (95% CI: 0.1-0.3%). Twenty-six (13.5%) of 193 swabs from children without active trachoma, and 58 (49.2%) of 118 swabs from children with active trachoma were positive for Ct DNA. Two hundred and ten (53%) of 397 children had anti-Pgp3 antibodies. Both infection (p<0.0001) and seropositivity (p<0.0001) were strongly associated with active trachoma. In 1-9-year-olds, the prevalence of anti-Pgp3 antibodies rose steeply with age.Trachoma presents a public health problem on Kiritimati, where the high prevalence of ocular Ct infection and rapid increase in seropositivity with age suggest intense Ct transmission amongst young children. Interventions are required here to prevent future blindness. In some Pacific Island countries, such as Solomon Islands and Fiji, active trachoma is common, but ocular Chlamydia trachomatis (Ct) infection and trachomatous trichiasis (TT) are rare. On Tarawa, the most populous Kiribati island, both the active trachoma sign "trachomatous inflammation-follicular" (TF) and TT are present at prevalences warranting intervention. We sought to estimate prevalences of TF, TT, ocular Ct infection, and anti-Ct antibodies on Kiritimati Island, Kiribati, to assess local relationships between these parameters, and to help determine the need for interventions against trachoma on Kiribati islands other than Tarawa. As part of the Global Trachoma Mapping Project (GTMP), on Kiritimati, we examined 406 children aged 1-9 years for active trachoma. We collected conjunctival swabs (for droplet digital PCR against Ct plasmid targets) from 1-9-year-olds with active trachoma, and a systematic selection of 1-9-year-olds without active trachoma. We collected dried blood spots (for anti-Pgp3 ELISA) from all 1-9-year-old children. We also examined 416 adults aged ≥15 years for TT. Prevalence of TF and TT was adjusted for age (TF) or age and gender (TT) in five-year age bands. The age-adjusted prevalence of TF in 1-9-year-olds was 28% (95% confidence interval [CI]: 24-35). The age- and gender-adjusted prevalence of TT in those aged ≥15 years was 0.2% (95% CI: 0.1-0.3%). Twenty-six (13.5%) of 193 swabs from children without active trachoma, and 58 (49.2%) of 118 swabs from children with active trachoma were positive for Ct DNA. Two hundred and ten (53%) of 397 children had anti-Pgp3 antibodies. Both infection (p<0.0001) and seropositivity (p<0.0001) were strongly associated with active trachoma. In 1-9-year-olds, the prevalence of anti-Pgp3 antibodies rose steeply with age. Trachoma presents a public health problem on Kiritimati, where the high prevalence of ocular Ct infection and rapid increase in seropositivity with age suggest intense Ct transmission amongst young children. Interventions are required here to prevent future blindness. |
Audience | Academic |
Author | Kiauea, Tokoriri Alexander, Neal D E Solomon, Anthony W Butcher, Robert M R Pickering, Harry Migchelsen, Stephanie J Cama, Anaseini Taoaba, Raebwebwe Itibita, Iakoba Le Mesurier, Richard T Bakhtiari, Ana Müller, Andreas Martin, Diana L Tekeraoi, Rabebe Roberts, Chrissy H Willis, Rebecca |
AuthorAffiliation | RTI International, UNITED STATES 3 Centre for Eye Research, University of Melbourne, Melbourne, Australia 10 Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland 2 The Fred Hollows Foundation, Sydney, Australia 8 MRC Tropical Epidemiology Group, Infectious Disease Epidemiology Department, London School of Hygiene & Tropical Medicine, London, United Kingdom 1 International Agency for the Prevention of Blindness, Western Pacific Region, Suva, Fiji 5 Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom 7 International Trachoma Initiative, Task Force for Global Health, Decatur, Georgia, United States of America 9 Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America 4 Eye Department, Ministry of Health and Medical Services, South Tarawa, Kiribati 6 Kiritimati Hospital, London, Kiritimati Island, Kiribati |
AuthorAffiliation_xml | – name: 4 Eye Department, Ministry of Health and Medical Services, South Tarawa, Kiribati – name: 1 International Agency for the Prevention of Blindness, Western Pacific Region, Suva, Fiji – name: 2 The Fred Hollows Foundation, Sydney, Australia – name: 3 Centre for Eye Research, University of Melbourne, Melbourne, Australia – name: 5 Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom – name: 7 International Trachoma Initiative, Task Force for Global Health, Decatur, Georgia, United States of America – name: RTI International, UNITED STATES – name: 6 Kiritimati Hospital, London, Kiritimati Island, Kiribati – name: 10 Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland – name: 8 MRC Tropical Epidemiology Group, Infectious Disease Epidemiology Department, London School of Hygiene & Tropical Medicine, London, United Kingdom – name: 9 Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America |
Author_xml | – sequence: 1 givenname: Anaseini surname: Cama fullname: Cama, Anaseini organization: The Fred Hollows Foundation, Sydney, Australia – sequence: 2 givenname: Andreas surname: Müller fullname: Müller, Andreas organization: Centre for Eye Research, University of Melbourne, Melbourne, Australia – sequence: 3 givenname: Raebwebwe surname: Taoaba fullname: Taoaba, Raebwebwe organization: Eye Department, Ministry of Health and Medical Services, South Tarawa, Kiribati – sequence: 4 givenname: Robert M R orcidid: 0000-0003-0435-2655 surname: Butcher fullname: Butcher, Robert M R organization: Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom – sequence: 5 givenname: Iakoba surname: Itibita fullname: Itibita, Iakoba organization: Kiritimati Hospital, London, Kiritimati Island, Kiribati – sequence: 6 givenname: Stephanie J surname: Migchelsen fullname: Migchelsen, Stephanie J organization: Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom – sequence: 7 givenname: Tokoriri surname: Kiauea fullname: Kiauea, Tokoriri organization: Kiritimati Hospital, London, Kiritimati Island, Kiribati – sequence: 8 givenname: Harry surname: Pickering fullname: Pickering, Harry organization: Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom – sequence: 9 givenname: Rebecca surname: Willis fullname: Willis, Rebecca organization: International Trachoma Initiative, Task Force for Global Health, Decatur, Georgia, United States of America – sequence: 10 givenname: Chrissy H surname: Roberts fullname: Roberts, Chrissy H organization: Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom – sequence: 11 givenname: Ana surname: Bakhtiari fullname: Bakhtiari, Ana organization: International Trachoma Initiative, Task Force for Global Health, Decatur, Georgia, United States of America – sequence: 12 givenname: Richard T surname: Le Mesurier fullname: Le Mesurier, Richard T organization: The Fred Hollows Foundation, Sydney, Australia – sequence: 13 givenname: Neal D E surname: Alexander fullname: Alexander, Neal D E organization: MRC Tropical Epidemiology Group, Infectious Disease Epidemiology Department, London School of Hygiene & Tropical Medicine, London, United Kingdom – sequence: 14 givenname: Diana L surname: Martin fullname: Martin, Diana L organization: Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America – sequence: 15 givenname: Rabebe surname: Tekeraoi fullname: Tekeraoi, Rabebe organization: Eye Department, Ministry of Health and Medical Services, South Tarawa, Kiribati – sequence: 16 givenname: Anthony W surname: Solomon fullname: Solomon, Anthony W organization: Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28898240$$D View this record in MEDLINE/PubMed |
BookMark | eNptUt2KGyEYHcqW7k_7BqUdKJRebFIddUZvFpbQn9CF7kV7LY6jGYPRVJ2FfYU-dZ1kNiRlGWTk85zj5_nOZXHmvFNF8RaCOUQN_Lz2Q3DCzrcudXMAAKE1elFcQIbIrGoQOTvanxeXMa4zhhEKXxXnFaWMVhhcFH_vg3oQVjmpSq_LaFYujpsUhOz9RlyXXg5WhHLRW7F57Iw4HCUTS-O0ksl4VwrX5ZVM6zujYpl8eb_aogwog4qmUy7tdH-YYJIZyeUy2ky63pXaXHhdvNTCRvVm-l8Vv79--bX4Prv7-W25uL2bybrCaaYIABIjrTHoUKeaupMMsYppralusGgpaQQlFONaUAClBoJArauWICQZqNBV8X6vu7U-8snGyCEjEBOESZMRyz2i82LNtyH3Gx65F4bvCj6suAjJSKu4EEwCDVtG2hZXNWvrilSNoq2qaUM0yFo3021Du1GdzEYEYU9ET0-c6fnKP3BSA9Y0Y7ufJoHg_wwqJr4xUSqbzVN-GPtGtAawQnWGfvgP-vzrJtQqz53nCfpxoqMovyWgQRQzMGrNn0Hlr1MbI3MUtcn1E8LHI0KvhE199HYY0xFPgXgPlMHHGJQ-mAEBH6P91DUfo82naGfau2MjD6SnLKN_maz4kQ |
CitedBy_id | crossref_primary_10_1111_ceo_13366 crossref_primary_10_1016_j_diagmicrobio_2018_11_001 crossref_primary_10_1038_s41467_018_07852_0 crossref_primary_10_1080_09286586_2023_2249546 crossref_primary_10_12688_wellcomeopenres_13423_1 crossref_primary_10_12688_wellcomeopenres_13423_2 crossref_primary_10_1186_s13071_018_2682_2 crossref_primary_10_4269_ajtmh_18_0082 crossref_primary_10_1038_s41598_023_33834_4 crossref_primary_10_1371_journal_pntd_0010275 crossref_primary_10_1093_cid_ciaa042 crossref_primary_10_1371_journal_pntd_0010273 crossref_primary_10_2147_OPTH_S448870 crossref_primary_10_1371_journal_pone_0207393 crossref_primary_10_1111_1753_6405_13179 crossref_primary_10_1038_s41598_017_15056_7 crossref_primary_10_1371_journal_pntd_0011441 crossref_primary_10_1016_j_jinf_2020_01_015 crossref_primary_10_4103_0366_6999_225063 crossref_primary_10_1371_journal_pntd_0007749 crossref_primary_10_4269_ajtmh_18_0799 crossref_primary_10_1371_journal_pntd_0010629 crossref_primary_10_5694_mja2_51735 crossref_primary_10_1038_s41598_021_86639_8 crossref_primary_10_1371_journal_pntd_0007027 crossref_primary_10_1371_journal_pntd_0007127 crossref_primary_10_1371_journal_pntd_0008316 crossref_primary_10_1080_09286586_2018_1545037 |
Cites_doi | 10.1016/S1473-3099(05)70304-2 10.1371/journal.pntd.0003763 10.1186/1471-2334-14-216 10.1371/journal.pntd.0005230 10.1038/srep18532 10.3109/09286586.2015.1037401 10.1002/14651858.CD001860.pub3 10.1136/bjo.18.11.625 10.1186/1475-2875-7-195 10.5694/j.1326-5377.2001.tb143622.x 10.1080/09286586.2016.1247876 10.1371/journal.pntd.0005267 10.1371/journal.pntd.0003555 10.1371/journal.pntd.0004863 10.1136/bjo.2008.151720 10.1093/trstmh/trw069 10.1002/0471721182 10.1371/journal.pntd.0001873 10.1016/0002-9394(65)93746-3 10.1016/j.diagmicrobio.2014.11.010 10.1016/S0140-6736(07)61602-X 10.1080/09286586.2016.1238946 10.1016/S2214-109X(13)70113-X 10.1371/journal.pntd.0004352 10.1016/S0140-6736(03)13909-8 10.1371/journal.pntd.0003826 10.1128/CMR.17.4.982-1011.2004 10.1128/JCM.00622-13 10.1016/S0140-6736(06)68695-9 10.1371/journal.pntd.0005080 10.18637/jss.v032.i06 10.1167/iovs.08-2414 10.1371/journal.pntd.0000986 10.5479/si.00775630.501.1 10.1016/S1473-3099(05)70116-X 10.1080/09286586.2016.1243718 10.1371/journal.pntd.0004798 10.1016/j.ophtha.2008.09.011 10.1080/09286586.2016.1243717 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2017 Public Library of Science 2017 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati. PLoS Negl Trop Dis11(9): e0005863. https://doi.org/10.1371/journal.pntd.0005863 2017 2017 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati. PLoS Negl Trop Dis11(9): e0005863. https://doi.org/10.1371/journal.pntd.0005863 |
Copyright_xml | – notice: COPYRIGHT 2017 Public Library of Science – notice: 2017 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati. PLoS Negl Trop Dis11(9): e0005863. https://doi.org/10.1371/journal.pntd.0005863 – notice: 2017 – notice: 2017 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati. PLoS Negl Trop Dis11(9): e0005863. https://doi.org/10.1371/journal.pntd.0005863 |
CorporateAuthor | Global Trachoma Mapping Project for the Global Trachoma Mapping Project |
CorporateAuthor_xml | – sequence: 0 name: for the Global Trachoma Mapping Project – name: Global Trachoma Mapping Project |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7QL 7SS 7T2 7T7 7U9 7X7 7XB 88E 8C1 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR C1K CCPQU DWQXO F1W FR3 FYUFA GHDGH H94 H95 H97 K9. L.G M0S M1P M7N P64 PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1371/journal.pntd.0005863 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Entomology Abstracts (Full archive) Health and Safety Science Abstracts (Full archive) Industrial and Applied Microbiology Abstracts (Microbiology A) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database (Proquest) Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea ASFA: Aquatic Sciences and Fisheries Abstracts Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality ProQuest Health & Medical Complete (Alumni) Aquatic Science & Fisheries Abstracts (ASFA) Professional Health & Medical Collection (Alumni Edition) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts Publicly Available Content Database (Proquest) (PQ_SDU_P3) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database Aquatic Science & Fisheries Abstracts (ASFA) Professional Technology Research Database ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Central China Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality Environmental Sciences and Pollution Management ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Health & Safety Science Abstracts Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Entomology Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ASFA: Aquatic Sciences and Fisheries Abstracts Engineering Research Database ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
DocumentTitleAlternate | Trachoma in Kiritimati Island, Kiribati |
EISSN | 1935-2735 |
Editor | French, Michael |
Editor_xml | – sequence: 1 givenname: Michael surname: French fullname: French, Michael |
EndPage | e0005863 |
ExternalDocumentID | 1951453457 oai_doaj_org_article_aa9c0f1b95bb4269b62527e8be6875f0 A507384906 10_1371_journal_pntd_0005863 28898240 |
Genre | Journal Article |
GeographicLocations | Kiribati United States--US Fiji Georgia |
GeographicLocations_xml | – name: Kiribati – name: Fiji – name: United States--US – name: Georgia |
GrantInformation_xml | – fundername: Medical Research Council grantid: MR/K012126/1 – fundername: Wellcome Trust – fundername: World Health Organization grantid: 001 – fundername: ; grantid: 098521 – fundername: ; grantid: 1954-0 – fundername: ; grantid: ARIES: 203145 – fundername: ; grantid: OAA-A-10-00051 – fundername: ; grantid: AID-OAA-A-11-00048 |
GroupedDBID | --- 123 29O 2WC 3V. 53G 5VS 7X7 88E 8C1 8FI 8FJ AAFWJ ABDBF ABUWG ACGFO ACIHN ACPRK ADBBV ADRAZ AEAQA AENEX AFKRA AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BENPR BPHCQ BVXVI BWKFM CCPQU CGR CS3 CUY CVF DIK DU5 E3Z EAP EAS EBD ECGQY ECM EIF EMOBN ESX F5P FPL FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR IHW IPNFZ ITC KQ8 M1P M48 M~E NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC PSQYO PV9 RIG RNS RPM RZL SV3 TR2 TUS UKHRP WOQ AAYXX CITATION AFPKN 7QL 7SS 7T2 7T7 7U9 7XB 8FD 8FK AZQEC C1K DWQXO F1W FR3 H94 H95 H97 K9. L.G M7N P64 PQEST PQUKI PRINS 7X8 5PM AAPBV ABPTK N95 |
ID | FETCH-LOGICAL-c624t-e500c43ff40d3de76dc93929fff8f74ab857a858446a801cf0a51ff2b533c9023 |
IEDL.DBID | RPM |
ISSN | 1935-2735 1935-2727 |
IngestDate | Sun Jul 02 11:04:23 EDT 2023 Tue Oct 22 15:02:08 EDT 2024 Tue Sep 17 21:21:16 EDT 2024 Fri Oct 25 00:39:07 EDT 2024 Thu Oct 10 16:43:52 EDT 2024 Tue Nov 19 21:12:24 EST 2024 Tue Nov 12 22:48:45 EST 2024 Tue Aug 20 22:08:56 EDT 2024 Fri Dec 06 02:45:27 EST 2024 Wed Oct 16 00:43:42 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Language | English |
License | World Health Organization. Licensee Public Library of Science. This is an open access article distributed under the Creative Commons Attribution IGO License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/3.0/igo/. In any use of this article, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article’s original URL. Creative Commons Attribution License |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c624t-e500c43ff40d3de76dc93929fff8f74ab857a858446a801cf0a51ff2b533c9023 |
Notes | new_version ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Membership of The Global Trachoma Mapping Project is provided in the Acknowledgments. AC and RTLM of the Fred Hollows Foundation were personally involved in the study, as indicated in the statement of authors’ contributions; otherwise, funders had no role in project design, in project implementation or analysis or interpretation of data, in the decisions on where, how or when to publish in the peer reviewed press, or in preparation of the manuscript. |
ORCID | 0000-0003-0435-2655 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609772/ |
PMID | 28898240 |
PQID | 1951453457 |
PQPubID | 1436337 |
ParticipantIDs | plos_journals_1951453457 doaj_primary_oai_doaj_org_article_aa9c0f1b95bb4269b62527e8be6875f0 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5609772 proquest_miscellaneous_1938601236 proquest_journals_1951453457 gale_infotracmisc_A507384906 gale_infotracacademiconefile_A507384906 gale_healthsolutions_A507384906 crossref_primary_10_1371_journal_pntd_0005863 pubmed_primary_28898240 |
PublicationCentury | 2000 |
PublicationDate | 2017-09-12 |
PublicationDateYYYYMMDD | 2017-09-12 |
PublicationDate_xml | – month: 09 year: 2017 text: 2017-09-12 day: 12 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
PublicationTitle | PLoS neglected tropical diseases |
PublicationTitleAlternate | PLoS Negl Trop Dis |
PublicationYear | 2017 |
Publisher | Public Library of Science Public Library of Science (PLoS) |
Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
References | B Kirkwood (ref18) 2003 AW Solomon (ref37) 2004; 17 SJ Migchelsen (ref21) 2017; 11 PH Corran (ref27) 2008; 7 I Mann (ref6) 1966 BE Elshafie (ref49) 2016; 23 AR Last (ref26) 2017 AF Macallan (ref5) 1934; 18 O Sokana (ref17) 2016; 23 EB Goodhew (ref40) 2014; 14 AM Ramadhani (ref38) 2016; 10 B Ward (ref4) 1965; 59 E von Elm (ref24) 2007; 370 AW Solomon (ref19) 2015; 22 HR Wright (ref41) 2005; 5 (ref10) 2013 C-E Michel (ref44) 2006; 367 DL Martin (ref35) 2015; 9 B Bero (ref48) 2016; 23 ref9 TH Adera (ref50) 2016; 23 DL Martin (ref34) 2015; 5 FR Thomas (ref46) 2003 N Cocks (ref14) 2016; 110 AW Solomon (ref30) 2003; 362 EB Goodhew (ref39) 2012; 6 ref2 Ch Roberts (ref20) 2013; 51 JR Evans (ref28) 2011 V Francis (ref11) 1995 RMR Butcher (ref16) 2016; 10 B Thylefors (ref8) 1987; 65 T Benaglia (ref23) 2009; 32 JL Smith (ref47) 2015; 9 RA Bourne (ref1) 2013; 1 MA Wolle (ref32) 2009; 50 SK West (ref36) 2016; 10 H Taylor (ref3) 2001; 175 CR Dawson (ref45) 1981 MJ Burton (ref33) 2015; 9 C-E Michel (ref43) 2011; 5 L Dize (ref25) 2015; 81 G McLachlan (ref22) 2000 ref29 AW Solomon (ref42) 2006; 6 F Taleo (ref13) 2017; 11 MA Wolle (ref31) 2009; 116 A Solomon (ref12) 2006 AA Mathew (ref7) 2009; 93 CK Macleod (ref15) 2016; 10 |
References_xml | – volume: 6 start-page: 5 year: 2006 ident: ref42 article-title: Clinical examination versus Chlamydia trachomatis assays to guide antibiotic use in trachoma control programmes publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(05)70304-2 contributor: fullname: AW Solomon – volume: 9 start-page: e0003763 year: 2015 ident: ref33 article-title: Pathogenesis of progressive scarring trachoma in ethiopia and Tanzania and its implications for disease control: two cohort studies publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0003763 contributor: fullname: MJ Burton – volume: 14 start-page: 216 year: 2014 ident: ref40 article-title: Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration publication-title: BMC Infect Dis doi: 10.1186/1471-2334-14-216 contributor: fullname: EB Goodhew – volume: 11 start-page: e0005230 year: 2017 ident: ref21 article-title: Defining Seropositivity Thresholds for Use in Trachoma Elimination Studies publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0005230 contributor: fullname: SJ Migchelsen – ident: ref9 – volume: 5 start-page: 18532 year: 2015 ident: ref34 article-title: Serological Measures of Trachoma Transmission Intensity publication-title: Sci Rep doi: 10.1038/srep18532 contributor: fullname: DL Martin – year: 1995 ident: ref11 article-title: Acheiving community support for trachoma control: a guide for district health work contributor: fullname: V Francis – ident: ref2 – volume: 22 start-page: 214 year: 2015 ident: ref19 article-title: The Global Trachoma Mapping Project: Methodology of a 34-Country Population-Based Study publication-title: Ophthalmic Epidemiol doi: 10.3109/09286586.2015.1037401 contributor: fullname: AW Solomon – year: 2011 ident: ref28 article-title: Antibiotics for trachoma publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD001860.pub3 contributor: fullname: JR Evans – volume: 18 start-page: 625 year: 1934 ident: ref5 article-title: Trachoma in the British Colonial Empire—its relation to blindness, the existing means of relief, means of prophylaxis publication-title: Br J Ophthalmol doi: 10.1136/bjo.18.11.625 contributor: fullname: AF Macallan – volume: 7 start-page: 195 year: 2008 ident: ref27 article-title: Dried blood spots as a source of anti-malarial antibodies for epidemiological studies publication-title: Malar J doi: 10.1186/1475-2875-7-195 contributor: fullname: PH Corran – volume: 175 start-page: 371 year: 2001 ident: ref3 article-title: Trachoma in Australia publication-title: Med J Aust doi: 10.5694/j.1326-5377.2001.tb143622.x contributor: fullname: H Taylor – volume: 23 start-page: 1 year: 2016 ident: ref50 article-title: Prevalence of and Risk Factors for Trachoma in Southern Nations, Nationalities, and Peoples’ Region, Ethiopia: Results of 40 Population-Based Prevalence Surveys Carried Out with the Global Trachoma Mapping Project publication-title: Ophthalmic Epidemiol doi: 10.1080/09286586.2016.1247876 contributor: fullname: TH Adera – volume: 11 start-page: e0005267 year: 2017 ident: ref13 article-title: Integrated mapping of yaws and trachoma in the five northern-most provinces Vanuatu publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0005267 contributor: fullname: F Taleo – year: 2006 ident: ref12 article-title: Trachoma control: a guide for program managers contributor: fullname: A Solomon – volume: 9 start-page: e0003555 year: 2015 ident: ref35 article-title: Serology for Trachoma Surveillance after Cessation of Mass Drug Administration publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0003555 contributor: fullname: DL Martin – volume: 10 start-page: e0004863 year: 2016 ident: ref16 article-title: Low Prevalence of Conjunctival Infection with Chlamydia trachomatis in a Treatment-Naïve Trachoma-Endemic Region of the Solomon Islands publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0004863 contributor: fullname: RMR Butcher – volume: 93 start-page: 866 year: 2009 ident: ref7 article-title: Trachoma in the Pacific Islands: evidence from Trachoma Rapid Assessment publication-title: Br J Ophthalmol doi: 10.1136/bjo.2008.151720 contributor: fullname: AA Mathew – volume: 110 start-page: 582 year: 2016 ident: ref14 article-title: Community seroprevalence survey for yaws and trachoma in the Western Division of Fiji publication-title: Trans R Soc Trop Med Hyg doi: 10.1093/trstmh/trw069 contributor: fullname: N Cocks – year: 2000 ident: ref22 article-title: Finite Mixture Models doi: 10.1002/0471721182 contributor: fullname: G McLachlan – volume: 6 year: 2012 ident: ref39 article-title: CT694 and pgp3 as Serological Tools for Monitoring Trachoma Programs publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0001873 contributor: fullname: EB Goodhew – year: 2017 ident: ref26 article-title: Spatial clustering of high load ocular Chlamydia trachomatis infection in trachoma: A cross-sectional population-based study publication-title: Pathog Dis contributor: fullname: AR Last – volume: 59 start-page: 458 year: 1965 ident: ref4 article-title: The prevalence of active trachoma in Fiji publication-title: Am J Ophthalmol doi: 10.1016/0002-9394(65)93746-3 contributor: fullname: B Ward – volume: 81 start-page: 102 year: 2015 ident: ref25 article-title: Evaluation of pooled ocular and vaginal swabs by the Cepheid GeneXpert CT/NG assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae compared to the GenProbe Aptima Combo 2 Assay publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2014.11.010 contributor: fullname: L Dize – volume: 370 start-page: 1453 year: 2007 ident: ref24 article-title: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies publication-title: Lancet doi: 10.1016/S0140-6736(07)61602-X contributor: fullname: E von Elm – ident: ref29 – volume: 23 start-page: 15 year: 2016 ident: ref17 article-title: Mapping trachoma in The Solomon Islands—results from the Global Trachoma Mapping Project publication-title: Ophthalmic Epidemiol doi: 10.1080/09286586.2016.1238946 contributor: fullname: O Sokana – year: 1981 ident: ref45 article-title: Guide to trachoma control in programmes for the prevention of blindness contributor: fullname: CR Dawson – volume: 1 start-page: e339 year: 2013 ident: ref1 article-title: Causes of vision loss worldwide, 1990–2010: a systematic analysis publication-title: Lancet Glob Heal doi: 10.1016/S2214-109X(13)70113-X contributor: fullname: RA Bourne – volume: 10 start-page: e0004352 year: 2016 ident: ref36 article-title: Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District Survey publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0004352 contributor: fullname: SK West – volume: 362 start-page: 198 year: 2003 ident: ref30 article-title: Strategies for control of trachoma: observational study with quantitative PCR publication-title: Lancet doi: 10.1016/S0140-6736(03)13909-8 contributor: fullname: AW Solomon – volume: 9 start-page: e0003826 year: 2015 ident: ref47 article-title: Multilevel Analysis of Trachomatous Trichiasis and Corneal Opacity in Nigeria: The Role of Environmental and Climatic Risk Factors on the Distribution of Disease publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0003826 contributor: fullname: JL Smith – volume: 17 start-page: 982 year: 2004 ident: ref37 article-title: Diagnosis and assessment of trachoma publication-title: Clin Microbiol Rev doi: 10.1128/CMR.17.4.982-1011.2004 contributor: fullname: AW Solomon – volume: 51 start-page: 2195 year: 2013 ident: ref20 article-title: Development and Evaluation of a Next-Generation Digital PCR Diagnostic Assay for Ocular Chlamydia trachomatis Infections publication-title: J Clin Microbiol doi: 10.1128/JCM.00622-13 contributor: fullname: Ch Roberts – year: 2013 ident: ref10 article-title: Trachoma Mapping in the Pacific – year: 1966 ident: ref6 article-title: Climate, race, culture and eye disease contributor: fullname: I Mann – volume: 367 start-page: 1585 year: 2006 ident: ref44 article-title: Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: a comparative study publication-title: Lancet doi: 10.1016/S0140-6736(06)68695-9 contributor: fullname: C-E Michel – volume: 10 year: 2016 ident: ref38 article-title: The Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic Treatment publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0005080 contributor: fullname: AM Ramadhani – volume: 32 start-page: 1 year: 2009 ident: ref23 article-title: mixtools: An R package for analyzing mixture models publication-title: J Stat Softw doi: 10.18637/jss.v032.i06 contributor: fullname: T Benaglia – volume: 50 start-page: 592 year: 2009 ident: ref32 article-title: Age, sex, and cohort effects in a longitudinal study of trachomatous scarring publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.08-2414 contributor: fullname: MA Wolle – volume: 5 start-page: e986 year: 2011 ident: ref43 article-title: Correlation of clinical trachoma and infection in Aboriginal communities publication-title: PLoS Neglected Trop Dis doi: 10.1371/journal.pntd.0000986 contributor: fullname: C-E Michel – year: 2003 ident: ref46 article-title: Kiribati: some aspects of human ecology, forty years later doi: 10.5479/si.00775630.501.1 contributor: fullname: FR Thomas – volume: 5 start-page: 313 year: 2005 ident: ref41 article-title: Clinical examination and laboratory tests for estimation of trachoma prevalence in a remote setting: what are they really telling us? publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(05)70116-X contributor: fullname: HR Wright – volume: 23 start-page: 381 year: 2016 ident: ref49 article-title: The Epidemiology of Trachoma in Darfur States and Khartoum State, Sudan: Results of 32 Population-Based Prevalence Surveys publication-title: Ophthalmic Epidemiol doi: 10.1080/09286586.2016.1243718 contributor: fullname: BE Elshafie – volume: 65 start-page: 477 year: 1987 ident: ref8 article-title: A simple system for the assessment of trachoma and its complications publication-title: Bull World Health Organ contributor: fullname: B Thylefors – start-page: 413 year: 2003 ident: ref18 article-title: Calculation of required sample size. Essentail Medical Statistics contributor: fullname: B Kirkwood – volume: 10 start-page: e0004798 year: 2016 ident: ref15 article-title: Low prevalence of ocular Chlamydia trachomatis infection and active trachoma in the Western Division of Fiji publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0004798 contributor: fullname: CK Macleod – volume: 116 start-page: 243 year: 2009 ident: ref31 article-title: Constant ocular infection with Chlamydia trachomatis predicts risk of scarring in children in Tanzania publication-title: Ophthalmology doi: 10.1016/j.ophtha.2008.09.011 contributor: fullname: MA Wolle – volume: 23 start-page: 392 year: 2016 ident: ref48 article-title: Prevalence of and Risk Factors for Trachoma in Oromia Regional State of Ethiopia: Results of 79 Population-Based Prevalence Surveys Conducted with the Global Trachoma Mapping Project publication-title: Ophthalmic Epidemiol doi: 10.1080/09286586.2016.1243717 contributor: fullname: B Bero |
SSID | ssj0059581 |
Score | 2.3935163 |
Snippet | In some Pacific Island countries, such as Solomon Islands and Fiji, active trachoma is common, but ocular Chlamydia trachomatis (Ct) infection and trachomatous... Objective In some Pacific Island countries, such as Solomon Islands and Fiji, active trachoma is common, but ocular Chlamydia trachomatis (Ct) infection and... OBJECTIVEIn some Pacific Island countries, such as Solomon Islands and Fiji, active trachoma is common, but ocular Chlamydia trachomatis (Ct) infection and... Ocular infection with Chlamydia trachomatis causes trachoma. It is the leading infectious cause of blindness, and the target of an international campaign for... Objective In some Pacific Island countries, such as Solomon Islands and Fiji, active trachoma is common, but ocular Chlamydia trachomatis (Ct) infection and... |
SourceID | plos doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | e0005863 |
SubjectTerms | Adults Age Antibiotics Antibodies Antibodies, Bacterial - blood Antigens, Bacterial - immunology Bacteria Bacterial Proteins - immunology Biology and Life Sciences Blindness Blood Child Child, Preschool Children Chlamydia Chlamydia infections Chlamydia trachomatis Confidence intervals Countries Deoxyribonucleic acid Diagnosis Disease Disease prevention Distribution DNA Earth Sciences ELISA Enzyme-Linked Immunosorbent Assay Epidemiology Gender Humans Hygiene Immunoglobulins Infant Infections Islands Medicine Medicine and Health Sciences Micronesia - epidemiology Nucleotide sequence PCR People and Places Plasmids Population Prevalence Properties Public health Research and Analysis Methods Risk factors Sexually transmitted diseases Spots STD Supervision Task forces Trachoma Trachoma - complications Trachoma - epidemiology Trachoma - microbiology Transmission Trichiasis - etiology Tropical diseases |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na9VAEF_kHcSLWL8arbqC4KWxyX7nWIulKBUPFnoL-2kfSPLwpYf-C_7VzmzyQiMFLx4CYWeysDOz2d-w80HIu1rXXsNRU9ZRGnRQQmlNlUrvGItJxFDlG_zzr-rsQny-lJe3Wn1hTNhYHngU3JG1ja9S7RrpHKZdOgDsTEfjogKonUZvvWI7Z2r8B8tG5vakgE4w44rpKWmO6_po0tGHTTcErF4ojeKLQynX7p__0KvNz357F_z8O4ry1rF0-og8nPAkPR7XsUfuxe4xuX8-3Zg_Ib-xRpPNmUW0TxTDNbb4AnNhmxR7SPsciUpPrsA2bsBaZtKw3tJdrFZHbRfgGdaux7hDOvT0248NBwYKDjt2Jh3yvF_WWCUJP6ZobV04zEMOBp6Si9NP30_Oyqn_QukVE0MZZVV5wVMSVeAhahV8g3AqpWSSFtYZqa0BBCMU6Lf2qbKyTok5gJC-ATDwjKy6vov7hLqQKh2Zcp7XwmntQp185EpZFziPoiDlTgHtZiyz0ea7Ng3uySjJFhXWTgoryEfU0syLRbLzAJhOO5lO-y_TKcgb1HE7ZpzOW709BozMjWgqVZD3mQM3OwrfTjkLsCgsm7XgPFhwwib1C_I-2tFuLdu2BmQrJBdSw5c727qb_HYm46QYE9fF_hp5uFG5BF9Bno-mOMuDGdMYAGsF0QsjXQhsSenWV7m6OEBg8AnYi_8h4ZfkAUMYlFtuHJDV8Os6vgIQN7jXeb_-AfaxRXs priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9UwFA96ByKI6NStOjWC4Mvq2iZN0ifZxsZQNoY42FtpvrYL0l53uwf_Bf9qz0nTamX4cOGSnIY25-Tkd5LzQcj7XOZGwlaT5q5UaKDYtFGZT40uCue5s1m4wT89EycX_PNleRkP3NbRrXLUiUFR287gGfleDlCAl4yX8tPqR4pVo_B2NZbQuE82ipwptSAbB0dn519HXVxWZShTCigFI68KGYPnmMz3Iq8-rtreYhbDUgk225xCDv9JUy9W37v1XTD0X2_Kv7an4yfkccSVdH8QhKfknms3yYPTeHO-SR4N53N0CDt6Rn5h7qYmRBzRzlN041jjHxgby6c0u7QLHqr08Bpk5idI0dTVL9d09OFqadNa-PVL3aE_Iu07en61YkBAwZDHiqV9GPfLErMn4cMUpbC1u6FJQ8NzcnF89O3wJI11GVIjCt6nrswyw5n3PLPMOimsqRBmee-Vl7zRqpSNAmTDBfA9Nz5rytz7QgO0NBWAhBdk0Xat2yZUW59JVwhtWM61lNrm3jgmRKMtY44nJB0ZUq-G9Bt1uIOTYLYMM1sjA-vIwIQcINcmWkyeHRq6m6s6rsW6aSqT-VxXpdYYyavBBiykU9oJsN58lpC3yPN6iESdVEC9D9iZKV5lIiEfAgUqAZz8JsYywEdhOq0Z5c6MEhavmXVvo1yN37Ku_4g5PDnK2t3d76ZuHBR95VrX3SINUyKk5kvI1iCa03wUSlUKQFxC5ExoZxM272mX1yHrOEBjsBWKl_9_rVfkYYHAJxTZ2CGL_ubWvQbY1us3cW3-Bpe4Qzo priority: 102 providerName: ProQuest – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3daxQxEA_1BBFEtGq7WjWC4Eu3bDbZTfZBpBZLUU588KBvS5JN2oOye95tof0X-lc7k_3AlevDwZGZhNuZyeY3l_kg5COTzEo4amLmMoUOShVrlfjYmjR1XrgqCTf485_52UJ8P8_Od8jQs7UX4Gara4f9pBbrq6ObP7dfYMN_Dl0bJBsmHa3qtsJ6hJnK-QPyMIWzEYO85mK8V8iKTLE-ge6-mZMDKtTxH9_Ws9VVs9kGRf-PqPzniDp9Rp722JIed8bwnOy4epc8mve357vkSfcfHe1Sj16QO6zfpEPWEW08xVCODX6BtbGFij6kTYhSpSeXYDe3YEkjqV1u6BDHVVNdV_Bpl6bBmETaNvTXxYoDAwVnHruWtmHdH0usoISTKVpiXR2GIQMDL8ni9Nvvk7O4780Q2zwVbeyyJLGCey-SildO5pUtEGp575WXQhuVSa0A3YgcdM-sT3TGvE8NwEtbAFB4RWZ1U7t9Qk3lE-nS3FjOhJHSVMxbx_Ncm4pzJyISDwopV10JjjLcw0lwXTrJlqjAsldgRL6i1kZeLKAdBpr1Rdnvx1LrwiaemSIzBrN5DfiBqXTKuBw8OJ9E5D3qvOyyUcfXQHkM-JkrUSR5RD4FDjRNFL7u8xngobCk1oTzYMIJG9hOyPtoV8OzbEoGqFdkXGQSZg62tp38YSTjohgvV7vmGnm4ykN5vojsdaY5yiNVqlAA5CIiJ0Y7EdiUUi8vQ-VxgMfgL6Sv7__Fb8jjFIFPaLJxQGbt-tq9BdjWmndhJ_4Fq5VD_w priority: 102 providerName: Scholars Portal |
Title | Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28898240 https://www.proquest.com/docview/1951453457 https://search.proquest.com/docview/1938601236 https://pubmed.ncbi.nlm.nih.gov/PMC5609772 https://doaj.org/article/aa9c0f1b95bb4269b62527e8be6875f0 http://dx.doi.org/10.1371/journal.pntd.0005863 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBbJFkovoe-4TbcqFHqJd_3Qy8dkSQgtG5bSwN6MJUvJQmIvWefQv9Bf3Rn5QVxy6mHNIo2ErZmxvrHmQcjXWMZGwlYTxpYrNFDKsFCRC41OEuuYLSN_gr-8FBdX7Puar_cI72NhvNO-0ZtZdXs3qzY33rdye2fmvZ_YfLVcwC4NsCWZ75N92H57E719_fKM-8qkAEww2CqRXbxcKuN5x57ZtmpKTFzIlcA6OolSmUrw88ejrcln8B_e05Ptbb17CoT-60v5aHM6f0kOOlRJT9q7f0X2bPWaPF925-ZvyB_M1FT4-CJaO4pOGzv8A3NhsZTimNbeH5UubkBCfoPMDF3NZkd7j62KFlUJv2aja_Q-pE1NV9fbFAgomO1Yn7Tx8_7YYK4kHExR5qry2DdpaHhLrs7Pfi0uwq4KQ2hEwprQ8igyLHWORWVaWilKkyGocs4pJ1mhFZeFAhzDBHA5Ni4qeOxcogFImgwgwTsyqerKHhKqSxdJmwht0phpKXUZO2NTIQpdpqllAQl7BuTbNtlG7k_cJBgp7UrmyLu8411ATpFLAy2myvYN9f113glMXhSZiVysM641xu1qsPgSaZW2Amw1FwXkM_I4b-NOB4XPTwApp4plkQjIN0-BKo-LX3SRC_BQmDxrRHk0ogRVNaPuQ5Sj_ll2eQz4lvGUcQkje9l6uvvL0I2TomdcZesHpEmV8In4AvK-FcVhPXrBDogcCelowcY9oHI-x3inYh_-e-RH8iJBBOSrbRyRSXP_YD8Bfmv0FLR2LeGqFvGUPDs9u1z9nPpvIXBdMjX1-vwXtLZK_w |
link.rule.ids | 230,314,727,780,784,864,885,2102,2221,12056,12223,21388,24318,27924,27925,31719,31720,33266,33267,33744,33745,43310,43579,43805,53791,53793,73745,74014,74302 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9UwFA96ByqI6PxYdboIgi-ra5ukSZ9kGxtXt3sZssHeSpMm2wVpr7vdg_-Cf7XnpOnVyvDhwiU5DW3OycnvJOeDkA-pTI2ErSZOrVBooNRxpRIXG51l1nFbJ_4GfzbPpxf866W4DAduq-BWOehEr6jr1uAZ-V4KUIALxoX8vPwRY9UovF0NJTTukw3MnC4mZOPgaH72bdDFohC-TCmgFIy8ymQInmMy3Qu8-rRsuhqzGAqVs9Hm5HP4rzX1ZPm9Xd0FQ__1pvxrezp-Sp4EXEn3e0F4Ru7ZZpM8mIWb803yuD-fo33Y0XPyC3M3VT7iiLaOohvHCv_A2Fg-pdqlrfdQpYfXIDM_QYrWXd1iRQcfroZWTQ2_bqFb9EekXUvPrpYMCCgY8lixtPPjniwwexI-TFEKm3rXN2loeEEujo_OD6dxqMsQmzzjXWxFkhjOnONJzWor89oUCLOcc8pJXmklZKUA2fAc-J4al1QidS7TAC1NASDhJZk0bWO3CNW1S6TNcm1YyrWUuk6dsSzPK10zZnlE4oEh5bJPv1H6OzgJZks_syUysAwMjMgBcm1Ni8mzfUN7c1WGtVhWVWESl-pCaI2RvBpswExapW0O1ptLIrKDPC_7SNS1Cij3ATszxYskj8hHT4FKACe_CrEM8FGYTmtEuT2ihMVrRt1bKFfDt6zKP2IOTw6ydnf3-3U3Doq-co1tb5GGqdyn5ovIq1401_ORKVUoAHERkSOhHU3YuKdZXPus4wCNwVbIXv__tXbIw-n57LQ8_TI_eUMeZQiCfMGNbTLpbm7tW4BwnX4X1ulv1k1GIg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEF_0CkUQ0apttNoVBF8am2Q32c2TtLVHtfY4xELfQvarPZDk7KUP_gv-1c5sNqeR4kMg7E6WZGd29jfZ-SDkbSpSLWCriVObSzRQTFzLxMVaZZl13JrEn-Cfz4rTC_75Mr8M_k-r4FY56ESvqE2r8R_5QQpQgOeMgwHvglvE_OP0w_JHjBWk8KQ1lNO4TzZgV0yyCdk4OpnNvw56OS9zX7IUEAtGYWUiBNIxkR4Evr1fNp3BjIa5LNhoo_L5_Ndae7L83q7ugqT_elb-tVVNH5NHAWPSw14onpB7ttkim-fhFH2LPOz_1dE-BOkp-YV5nGoffURbR9GlY4U3MDaWUqn3aeu9VenxNcjPT5CodVe3WNHBn6uhdWPg6haqRd9E2rV0frVkQEDBqMfqpZ0f92yBmZTwYYoS2Zh936Sg4Rm5mJ58Oz6NQ42GWBcZ72KbJ4nmzDmeGGasKIwuEXI556QTvFYyF7UElMMLkIFUu6TOU-cyBTBTlwAYnpNJ0zZ2h1BlXCJsVijNUq6EUCZ12rKiqJVhzPKIxANDqmWfiqPy53ECTJh-ZitkYBUYGJEj5NqaFhNp-4b25qoK67Kq61InLlVlrhRG9SqwBzNhpbIFWHIuicge8rzqo1LX6qA6BBzNJC-TIiLvPAUqBJz8OsQ1wEdhaq0R5e6IEhayHnXvoFwN37Kq_og8PDnI2t3db9bdOCj6zTW2vUUaJgufpi8i271orucjk7KUAOgiIkZCO5qwcU-zuPYZyAEmg92Qvfj_a-2RTVii1ZdPs7OX5EGGeMjX3tglk-7m1r4CNNep12GZ_gYhI0pP |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+of+signs+of+trachoma%2C+ocular+Chlamydia+trachomatis+infection+and+antibodies+to+Pgp3+in+residents+of+Kiritimati+Island%2C+Kiribati&rft.jtitle=PLoS+neglected+tropical+diseases&rft.au=Anaseini+Cama&rft.au=M%C3%BCller%2C+Andreas&rft.au=Taoaba%2C+Raebwebwe&rft.au=Butcher%2C+Robert&rft.date=2017-09-12&rft.pub=Public+Library+of+Science&rft.eissn=1935-2735&rft.volume=11&rft.issue=9&rft_id=info:doi/10.1371%2Fjournal.pntd.0005863&rft.externalDocID=1951453457 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1935-2735&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1935-2735&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1935-2735&client=summon |